跳至主要内容
临床试验/CTRI/2017/11/010683
CTRI/2017/11/010683招募中未知

Parotid Sparing Adaptive Radiotherapy in Head and Neck Cancer Patients â?? A Study Evaluating the Resource Intensiveness and Impact on Quality Of Life - PARITY

Tata Medical Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Pathologically proven squamous cell carcinomas of head and neck including oropharynx, hypopharynx, larynx and nasopharynx.
  • History and physical examination prior to the start of the treatment. For those undergoing radical treatment physical examination should have been done as recent as two weeks prior to the start of the treatment.
  • CT of the Head and Neck region, CT Chest to be done as part of the staging protocol.
  • 2. Age between 18 â?? 70 years
  • 3. ECOG 0 or 1
  • 4. Undergoing radical or adjuvant radiation/chemoradiation and requires bilateral neck irradiation.
  • 5. One or both parotids are intended to receive at least a dose between 25 â?? 30 Gy in the initial plan.
  • No exceptions to the eligibility criteria are permitted.

排除标准

  • 1. Prior surgery of the parotid glands
  • 2. Prior radiation therapy to the head and neck region.
  • 3. Prior cytotoxic chemotherapy
  • 4. Patients having xerostomia as per the pre radiotherapy evaluation
  • 5. Both the parotids are receiving more than 50 Gy in the initial plan.
  • 6. Patients with distant metastases.
  • 7. Unlikely to be on follow up with us after completion of radiotherapy.

研究者

发起方
Tata Medical Centre

相似试验

Parotid Sparing Adaptive Radiotherapy | 临床试验